Loading...

AEMD AETHLON MEDICAL INC Product Launches 8-K Filing

THLN

MD

AETHLON MEDICAL INC

(AEMD)

2024 8-K

Shareholder Approvals

Financial Results Update

Warrant Amendments

Funding Agreement

Quarterly Results

Nasdaq Compliance Regained

Nasdaq Compliance Notice

Stock Split Announcement

Share Count Update

Stock Offering Announcement

Corporate Presentation Update

Financial Results Report

Financial Statements

Reverse Stock Split

Warrant Agreement

Financial Results

Nasdaq Compliance

Financial Results

Clinical Trial Launch

Management Changes

Equity Plan Update

Clinical Trial Approval

Financial Results

Clinical Trial Approval

Dismissal of Independent Re...

Earnings Report

Public Offering

Presentation Update

Financial Results Announcement

Amendment to Compensation A...

Resignation of Director

Financial Results Announcement

Departure of CEO and Appoin...

Reverse Stock Split

Annual Meeting of Stockholders

Financial Results Announcement

Financial Results Announcement

Extension Granted

External Links:

Aethlon Medical announced the enrollment of the first patient in a clinical trial in Australia for its Hemopurifier device aimed at treating solid tumors that do not respond to anti-PD-1 antibodies.

AI Assistant

AETHLON MEDICAL INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.